Smbatyan G - Search Results

1

Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists.

Zhao Y, Wu K, Wu Y, Melendez E, Smbatyan G, Massiello D, Kahn M. Zhao Y, et al. Among authors: smbatyan g. Curr Mol Pharmacol. 2018;11(2):113-121. doi: 10.2174/1874467210666170919155739. Curr Mol Pharmacol. 2018. PMID: 28933312

2

CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells.

Zhao Y, Masiello D, McMillian M, Nguyen C, Wu Y, Melendez E, Smbatyan G, Kida A, He Y, Teo JL, Kahn M. Zhao Y, et al. Among authors: smbatyan g. Oncogene. 2016 Jul 14;35(28):3705-17. doi: 10.1038/onc.2015.438. Epub 2015 Dec 14. Oncogene. 2016. PMID: 26657156 Free PMC article.

3

Small molecule p300/catenin antagonist enhances hematopoietic recovery after radiation.

Zhao Y, Wu K, Nguyen C, Smbatyan G, Melendez E, Higuchi Y, Chen Y, Kahn M. Zhao Y, et al. Among authors: smbatyan g. PLoS One. 2017 May 9;12(5):e0177245. doi: 10.1371/journal.pone.0177245. eCollection 2017. PLoS One. 2017. PMID: 28486541 Free PMC article.

4

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer.

Ring A, Nguyen C, Smbatyan G, Tripathy D, Yu M, Press M, Kahn M, Lang JE. Ring A, et al. Among authors: smbatyan g. Cancers (Basel). 2018 Dec 19;10(12):525. doi: 10.3390/cancers10120525. Cancers (Basel). 2018. PMID: 30572639 Free PMC article.

5

Metabolism of orthotopic mouse brain tumor models.

Rosol M, Harutyunyan I, Xu J, Melendez E, Smbatyan G, Finlay JL, Krieger MD, Gonzalez-Gomez I, Reynolds CP, Nelson MD, Erdreich-Epstein A, Blüml S. Rosol M, et al. Among authors: smbatyan g. Mol Imaging. 2009 Jul-Aug;8(4):199-208. Mol Imaging. 2009. PMID: 19728974

6

Novel cell lines established from pediatric brain tumors.

Xu J, Erdreich-Epstein A, Gonzalez-Gomez I, Melendez EY, Smbatyan G, Moats RA, Rosol M, Biegel JA, Reynolds CP. Xu J, et al. Among authors: smbatyan g. J Neurooncol. 2012 Apr;107(2):269-80. doi: 10.1007/s11060-011-0756-5. Epub 2011 Nov 27. J Neurooncol. 2012. PMID: 22120608 Free PMC article.

7

VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer.

Ghate NB, Kim S, Spiller E, Kim S, Shin Y, Rhie SK, Smbatyan G, Lenz HJ, Mumenthaler SM, An W. Ghate NB, et al. Among authors: smbatyan g. Mol Oncol. 2021 Oct;15(10):2801-2817. doi: 10.1002/1878-0261.13068. Epub 2021 Aug 8. Mol Oncol. 2021. PMID: 34312968 Free PMC article.

8

Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy.

Shi X, Cheng Q, Hou T, Han M, Smbatyan G, Lang JE, Epstein AL, Lenz HJ, Zhang Y. Shi X, et al. Among authors: smbatyan g. Mol Ther. 2020 Feb 5;28(2):536-547. doi: 10.1016/j.ymthe.2019.11.020. Epub 2019 Nov 27. Mol Ther. 2020. PMID: 31843452 Free PMC article.

9

Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy.

Dai Z, Zhang XN, Cheng Q, Fei F, Hou T, Li J, Abdolvahabi A, Watanabe J, Pei H, Smbatyan G, Xie J, Lenz HJ, Louie SG, Zhang Y. Dai Z, et al. Among authors: smbatyan g. J Control Release. 2021 Aug 10;336:433-442. doi: 10.1016/j.jconrel.2021.06.041. Epub 2021 Jun 29. J Control Release. 2021. PMID: 34197861 Free PMC article.

10

Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity.

Cheng Q, Shi X, Han M, Smbatyan G, Lenz HJ, Zhang Y. Cheng Q, et al. Among authors: smbatyan g. J Am Chem Soc. 2018 Dec 5;140(48):16413-16417. doi: 10.1021/jacs.8b10047. Epub 2018 Nov 19. J Am Chem Soc. 2018. PMID: 30452238 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page